BPC-157 vs ARA-290: What’s the Difference?
The main difference between BPC-157 and ARA-290 is mechanism: BPC-157 is studied for tendon, ligament, and gut healing research — Stable peptide derived from gastric juice. ARA-290 is studied for neuropathy and tissue repair research — Engineered peptide from EPO.
Soft-tissue healing vs nerve tissue protection.
Key differences between BPC-157 and ARA-290
- •Mechanism: BPC-157 — Stable peptide derived from gastric juice. ARA-290 — Engineered peptide from EPO.
- •Primary research focus: BPC-157 is studied for tendon, ligament, and gut healing research; ARA-290 is studied for neuropathy and tissue repair research.
- •Depth of human research: BPC-157 — Limited; ARA-290 — Limited.
- •Typical study cadence cited in the literature: BPC-157 — Daily — local injection near injury when targeting tissue; ARA-290 — Daily.
| Attribute | BPC-157 Body Protection Compound 157 | ARA-290 Cibinetide |
|---|---|---|
| Category | Healing & Recovery | Immune System & Inflammation |
| Best known for | Tendon, ligament, and gut healing research | Neuropathy and tissue repair research |
| Mechanism of action | Stable peptide derived from gastric juice. Accelerates tendon, ligament, and gut lining repair. | Engineered peptide from EPO. Activates innate repair pathways. Targets neuropathic pain. |
| Human research | Limited | Limited |
| Animal research | Strong | Moderate |
| Mechanistic research | Emerging | Emerging |
| Study cadence cited | Daily — local injection near injury when targeting tissue | Daily |
| In plain English | Think of BPC-157 as the peptide that researchers reach for when they want to study how soft tissue heals — tendons, ligaments, the gut lining, and connective tissue. It's been studied heavily in animal models for repair. | ARA-290 isolates the tissue-healing effects of EPO without the red-blood-cell-boosting effects. |
| How it works | In animal studies it appears to promote new blood vessel formation (angiogenesis), increase growth factor receptor expression (especially VEGFR2), and modulate the nitric oxide system. The net effect in research models is faster tissue repair. | Selectively activates the innate repair receptor (IRR), promoting tissue protection and repair without erythropoiesis. |
| Researchers study | Tendon-to-bone healing, ligament repair, gut barrier integrity, ulcer healing, muscle crush injury recovery, and brain–gut axis modulation. | Diabetic neuropathy, sarcoidosis-related small-fiber neuropathy, and tissue repair. |
| Internet discussion | Online forums (Reddit's r/Peptides, AnabolicMinds, longevity Twitter) treat BPC-157 as the default 'recovery stack' addition. Stories range from rotator cuff and tendinopathy anecdotes to gut issues like IBS and leaky gut. | Niche discussion in chronic pain and neuropathy circles. |
Mechanism and research evidence, side by side
How BPC-157 and ARA-290 differ at the receptor level, and how much published research currently supports each. Evidence ratings describe the depth of publicly available literature — they are not claims of safety or effectiveness.
BPC-157
Stable peptide derived from gastric juice. Accelerates tendon, ligament, and gut lining repair.
- Local growth-factor and angiogenic signalling
- Cell migration, matrix remodelling and inflammatory modulation
- Connective-tissue, gut-lining and wound-repair endpoints
- Human research
- Limited
- Animal research
- Strong
- Mechanistic research
- Emerging
Tendon/ligament/joint healing, gut lining repair, IBD research
ARA-290
Engineered peptide from EPO. Activates innate repair pathways. Targets neuropathic pain.
- Local growth-factor and angiogenic signalling
- Cell migration, matrix remodelling and inflammatory modulation
- Connective-tissue, gut-lining and wound-repair endpoints
- Human research
- Limited
- Animal research
- Moderate
- Mechanistic research
- Emerging
Neuropathic pain (especially diabetic neuropathy), chronic tissue inflammation
BPC-157
Tendon, ligament, and gut healing research
Think of BPC-157 as the peptide that researchers reach for when they want to study how soft tissue heals — tendons, ligaments, the gut lining, and connective tissue. It's been studied heavily in animal models for repair.
In animal studies it appears to promote new blood vessel formation (angiogenesis), increase growth factor receptor expression (especially VEGFR2), and modulate the nitric oxide system. The net effect in research models is faster tissue repair.
Tendon-to-bone healing, ligament repair, gut barrier integrity, ulcer healing, muscle crush injury recovery, and brain–gut axis modulation.
Online forums (Reddit's r/Peptides, AnabolicMinds, longevity Twitter) treat BPC-157 as the default 'recovery stack' addition. Stories range from rotator cuff and tendinopathy anecdotes to gut issues like IBS and leaky gut.
BPC-157 is the most-discussed research peptide for soft-tissue repair, with strong animal data on tendons, ligaments, and gut healing. Human clinical data is limited.
ARA-290
Neuropathy and tissue repair research
ARA-290 isolates the tissue-healing effects of EPO without the red-blood-cell-boosting effects.
Selectively activates the innate repair receptor (IRR), promoting tissue protection and repair without erythropoiesis.
Diabetic neuropathy, sarcoidosis-related small-fiber neuropathy, and tissue repair.
Niche discussion in chronic pain and neuropathy circles.
ARA-290 is an EPO-derived peptide researched for tissue repair and neuropathy without RBC effects.